Umb Bank, N.A. Myriad Genetics Inc Transaction History
Umb Bank, N.A.
- $6.22 Billion
- Q4 2024
A detailed history of Umb Bank, N.A. transactions in Myriad Genetics Inc stock. As of the latest transaction made, Umb Bank, N.A. holds 254 shares of MYGN stock, worth $3,152. This represents 0.0% of its overall portfolio holdings.
Number of Shares
254
Previous 207
22.71%
Holding current value
$3,152
Previous $5,000
40.0%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding MYGN
# of Institutions
244Shares Held
91.2MCall Options Held
100KPut Options Held
34K-
Black Rock Inc. New York, NY15.2MShares$188 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.3MShares$128 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA6.72MShares$83.4 Million0.03% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny5.18MShares$64.2 Million0.07% of portfolio
-
State Street Corp Boston, MA4.7MShares$58.4 Million0.01% of portfolio
About MYRIAD GENETICS INC
- Ticker MYGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 80,634,800
- Market Cap $1B
- Description
- Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...